Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-10.4%
5Y CAGR+40.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-10.4%/yr
vs +50.7%/yr prior
5Y CAGR
+40.8%/yr
Recent deceleration
Acceleration
-61.1pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
5.5x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $139.15M | -40.5% |
| 2024 | $234.06M | -0.8% |
| 2023 | $235.95M | +21.9% |
| 2022 | $193.58M | -10.1% |
| 2021 | $215.21M | +756.8% |
| 2020 | $25.12M | -45.8% |
| 2019 | $46.30M | +23.3% |
| 2018 | $37.56M | +59.9% |
| 2017 | $23.49M | -6.7% |
| 2016 | $25.17M | - |